FLEURY S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.58 BRL | +4.07% |
|
-1.08% | -19.12% |
| May. 10 | Fleury Seeks Acquisitions | CI |
| May. 10 | Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024 |
ETFs positioned on Fleury S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 14 M€ | -1.97% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 112 M€ | +5.62% | - | |
| 0.00% | 7 M€ | +6.66% | - | |
| 0.00% | 34 M€ | +4.39% | - |
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-06-04
- Bradesco BBI London Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
14.35
BRL
Average target price
19.33
BRL
Spread / Average Target
+34.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.12% | 1.53B | |
| -15.71% | 8.57B | |
| +65.31% | 4.3B | |
| -9.46% | 2.47B | |
| -2.16% | 2.46B | |
| -44.11% | 2.31B | |
| -7.42% | 1.93B | |
| -41.75% | 1.2B | |
| +11.31% | 1.14B | |
| +16.15% | 986M |
- Stock Market
- Equities
- FLRY3 Stock
- Funds and ETFs Fleury S.A.
